Bio-Techne (TECH) Equity Income (2023 - 2026)
Bio-Techne (TECH) recorded quarterly Equity Income of -$739000.0 in Q1 2026, down 771.82% quarter-over-quarter from $110000.0 in Q4 2025, and down 25.47% on a YoY basis from -$991505.7 in Q1 2025.
Bio-Techne (TECH) Equity Income (2023 - 2026) Analysis & Trends
Bio-Techne's Equity Income history runs 4 years deep, the most recent figure standing at -$739000.0 for Q1 2026.
- In Q1 2026, Equity Income fell 25.47% year-over-year to -$739000.0; the TTM figure through Mar 2026 stood at $772000.0 (up 172.83% YoY), while the FY2025 annual figure was $938000.0, up 113.71% from the prior year.
- Equity Income was -$739000.0 for Q1 2026 at Bio-Techne, down from $110000.0 in the prior quarter.
- In the past five years, Equity Income ranged from a high of $1.1 million in Q2 2025 to a low of -$2.3 million in Q3 2023.
- Historically, Equity Income has averaged -$567181.8 across 4 years, with a median of -$589000.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Equity Income surged 224.24% in 2025, then decreased 25.47% in 2026.
- A 4-year view of Equity Income shows it stood at -$1.9 million in 2023, then surged by 102.4% to $46000.0 in 2024, then soared by 139.13% to $110000.0 in 2025, then plunged by 771.82% to -$739000.0 in 2026.
- The last three Equity Income figures came in at -$739000.0 (Q1 2026), $110000.0 (Q4 2025), and $294000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | -739,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -739,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 294,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | -589,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 374,000.00 |
| Jun 30, 2024 | -891,000.00 |
| Mar 31, 2024 | -1.75 Mn |
| Dec 31, 2023 | -1.91 Mn |
| Sep 30, 2023 | -2.29 Mn |